Suicidality is most centrally situated within network of depression symptom criteria in unipolar depression patients with mood stabilizer in Asia

Asian J Psychiatr. 2024 Nov:101:104197. doi: 10.1016/j.ajp.2024.104197. Epub 2024 Aug 30.

Abstract

Lithium and mood stabilizers are considered effective augmentation agents of antidepressants for treatment-resistant depression. Thus, this study aimed to estimate the network structure of depression symptom criteria among unipolar depression patients with mood stabilizers, using data from the Research on Asian Psychotropic Prescription Patterns for mood stabilizers (REAP-MS). We estimated a network of the 9 depression symptom criteria among 411 unipolar depression patients in Asia. Each of the depression symptom criteria was considered to be a dichotomous categorical variable. Suicidality (suicidal ideation or attempt) was the most centrally situated within the network of depression symptoms, followed by depressed mood, loss of energy, anhedonia and weight loss or gain. Contrastingly, concentration problem was the least interconnected. The depression symptom criteria were organized into 4 clusters by the community detection method. The findings suggest that suicidality may be one of the significant therapeutic target symptoms in unipolar depression patients with mood stabilizers.

Keywords: Asia; Lithium; Mood stabilizer; Network analysis; Suicidality; Unipolar depression.

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use
  • Antimanic Agents / therapeutic use
  • Asia
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / epidemiology
  • Depressive Disorder, Treatment-Resistant / diagnosis
  • Depressive Disorder, Treatment-Resistant / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Suicidal Ideation*
  • Suicide, Attempted / statistics & numerical data
  • Young Adult

Substances

  • Antimanic Agents
  • Antidepressive Agents